全文获取类型
收费全文 | 839篇 |
免费 | 52篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 44篇 |
妇产科学 | 25篇 |
基础医学 | 120篇 |
口腔科学 | 36篇 |
临床医学 | 57篇 |
内科学 | 158篇 |
皮肤病学 | 16篇 |
神经病学 | 16篇 |
特种医学 | 145篇 |
外国民族医学 | 1篇 |
外科学 | 59篇 |
综合类 | 65篇 |
一般理论 | 2篇 |
预防医学 | 61篇 |
眼科学 | 6篇 |
药学 | 35篇 |
中国医学 | 12篇 |
肿瘤学 | 38篇 |
出版年
2022年 | 8篇 |
2021年 | 18篇 |
2020年 | 18篇 |
2019年 | 13篇 |
2018年 | 19篇 |
2017年 | 15篇 |
2016年 | 18篇 |
2015年 | 19篇 |
2014年 | 28篇 |
2013年 | 39篇 |
2012年 | 40篇 |
2011年 | 34篇 |
2010年 | 54篇 |
2009年 | 46篇 |
2008年 | 27篇 |
2007年 | 25篇 |
2006年 | 19篇 |
2005年 | 13篇 |
2004年 | 12篇 |
2003年 | 11篇 |
2002年 | 9篇 |
2001年 | 6篇 |
2000年 | 11篇 |
1999年 | 10篇 |
1998年 | 34篇 |
1997年 | 34篇 |
1996年 | 34篇 |
1995年 | 37篇 |
1994年 | 23篇 |
1993年 | 20篇 |
1992年 | 4篇 |
1991年 | 6篇 |
1990年 | 7篇 |
1989年 | 16篇 |
1988年 | 15篇 |
1987年 | 13篇 |
1986年 | 16篇 |
1985年 | 10篇 |
1984年 | 13篇 |
1983年 | 14篇 |
1982年 | 13篇 |
1981年 | 13篇 |
1980年 | 15篇 |
1979年 | 6篇 |
1978年 | 9篇 |
1977年 | 3篇 |
1976年 | 9篇 |
1975年 | 7篇 |
1974年 | 2篇 |
1973年 | 3篇 |
排序方式: 共有897条查询结果,搜索用时 15 毫秒
71.
72.
BACKGROUND: Chagas' disease, caused by the protozoan parasite Trypanosoma cruzi, is endemic to Latin America and may be transmitted in the United States via blood donated by infected immigrants. Blood- borne pathogens such as T. cruzi require supplemental testing for confirmation of seroreactivity. STUDY DESIGN AND METHODS: A study was undertaken to determine an optimal scheme for confirmation of seroreactivity in repeatedly reactive samples identified by the Chagas antibody enzyme immunoassay (EIA). The procedure for initial confirmation involves three purified antigens coated onto three separate polystyrene beads and uses an EIA format. If the sample is reactive with two of three or three of three antigens, it is confirmed as seroreactive. If none or one of three beads is reactive, the sample is indeterminate and subjected to a radioimmunoprecipitation assay (RIPA). The RIPA must demonstrate characteristic bands at 32, 34, and 90 kDa. RESULTS: When tested with sera from persons with potentially cross-reactive diseases (n = 39) or against a presumed negative population from southeast Wisconsin (n = 289), the confirmatory EIA had a specificity of 100 percent. Sensitivity was 100 percent (28/28) with xenodiagnosis-positive sera and 97.6 percent (80/82) with chagasic sera from Latin America. The RIPA showed a specificity of 100 percent in EIA- nonreactive samples (n = 100) and a sensitivity of 100 percent with both xenodiagnosis-positive (28/28) and chagasic (82/82) sera. CONCLUSION: The confirmatory EIA and the RIPA together provide a highly specific and sensitive means of confirming seroreactivity for antibodies to T. cruzi. 相似文献
73.
74.
75.
D Saldanha N Kumar VSSR Ryali K Srivastava AA Pawar 《Medical Journal Armed Forces India》2009,65(2):108-112
Background
Serotonin plays an important role in treatment of depression. We evaluated the clinical correlates of plasma serotonin levels in depressed patients before and after treatment.Methods
Study sample comprised of 40 patients diagnosed on ICD-10 diagnostic criteria, and an equal number of healthy matched controls. Subjects were evaluated on Beck''s Depression Inventory (BDI) and Suicide Ideation Scale (SIS), before and after the treatment. Blood samples were collected from all the cases and controls before starting the antidepressant medication with selective serotonin reuptake inhibitors (SSRI''s). Serum serotonin levels were measured before and after treatment.Result
Significant differences in scores before and after the intervention on BDI, SIS and serotonin levels of cases and controls (p<.000) were noted. Correlation between the serum serotonin levels before and after the treatment, and between the rating scales did not reveal significant association (p > 0.05). Patients with suicidal intentions had lower levels of serotonin. The scores changed after intervention.Conclusion
Treatment with SSRI''s had shown significant changes in clinical conditions. However these changes did not relate significantly with serum serotonin levels.Key Words: Serotonin, Depression, Selective serotonin reuptake inhibitors 相似文献76.
EM Maier J Pongratz AC Muntau B Liebl U Nennstiel-Ratzel U Busch R Fingerhut B Olgemöller AA Roscher W Röschinger 《Clinical genetics》2009,76(2):179-187
Medium‐chain acyl‐CoA dehydrogenase deficiency (MCADD) represents a potentially fatal fatty acid β‐oxidation disorder. Newborn screening (NBS) by tandem mass spectrometry (MS/MS) has been implemented worldwide, but is associated with unresolved questions regarding population heterogeneity, burden on healthy carriers, cut‐off policies, false‐positive and negative rates. In a retrospective case‐control study, 333 NBS samples showing borderline acylcarnitine patterns but not reaching recall criteria were genotyped for the two most common mutations (c.985A>G/c.199C>T) and compared with genotypes and acylcarnitines of 333 controls, 68 false‐positives, and 34 patients. c.985A>G was more frequently identified in the study group and false‐positives compared to controls (1:4.3/1:2.3 vs. 1:42), whereas c.199C>T was found more frequently only within the false‐positives (1:23). Biochemical criteria were devised to differentiate homozygous (c.985A>G), compound heterozygous (c.985A>G/c.199C>T), and heterozygous individuals. Four false‐negatives were identified because our initial algorithm required an elevation of octanoylcarnitine (C8) and three secondary markers in the initial and follow‐up sample. The new approach allowed a reduction of false‐positives (by defining high cut‐offs: 1.4 μmol/l for C8; 7 for C8/C12) and false‐negatives (by sequencing the ACADM gene of few suspicious samples). Our validation strategy is able to differentiate healthy carriers from patients doubling the positive predictive value (42→88%) and to target NBS to MCADD‐subsets with potentially higher risk of adverse outcome. It remains controversial, if NBS programs should aim at identifying all subsets of all diseases included. Because the natural course of milder variants cannot be assessed by observational studies, our strategy could serve as a general model for evaluation of MS/MS‐based NBS. 相似文献
77.
Silvio ST Tafuri Domenico DM Martinelli Giovanni GC Caputi Annamaria AA Arbore Cinzia CG Germinario Rosa RP Prato 《BMC health services research》2009,9(1):100-5
Background
Mandatory vaccination has contributed to the success of immunisation programmes but voluntary vaccination allows people to be responsible for their own health. There are benefits from both policies and the arguments between them remain subject to debate within and without the scientific community, both nationally and internationally. The aim of this study is to assess the opinions of those who actually work in the Vaccination Service. 相似文献78.
Ade Fatai Adeniyi PhD Abubakar Sadik Mohammed BSc Olusola Ayanniyi PhD 《Hong Kong Physiotherapy Journal》2011,29(1):34-39
Poor adiposities are risk factors for major morbidities, but reports on how these relate with gait function of stroke patients undergoing rehabilitation is sparse and need further investigation. A convenience sample of 94 ambulatory stroke survivors and 94 matched apparently healthy individuals were assessed for adiposity markers (body mass index, waist circumference, thigh girth, waist-hip ratio, and percent body fat) and gait parameters (cadence, step length, stride length, stride width, gait velocity, and cycle). Mean age of the stroke and apparently healthy participants were 57 ± 5.2 years and 56.9 ± 4.8 years, respectively. We found significant (p < 0.05) relationships between waist circumference and each of gait cycle (r = 0.67) namely, cadence (r = −0.68), stride length (−0.62), step length (−0.61), and gait velocity (−0.75). Fairly similar correlations existed between body mass index, waist-hip ratio, percent body fat, thigh girth, and each of gait parameters, with only the thigh girth significantly correlating with stride width (r = 0.79). Obesity more than triples the odds of low gait velocities (odds ratio: 3.28; 95% confidence interval: 1.60–6.74). Findings provide clinicians with likely influence of adiposities on gait parameters of stroke patients. This may inform treatment decision and help to prioritize interventions through adiposity management for stroke patients undergoing rehabilitation. 相似文献
79.
80.
C. Boulanger NA Flavahan ZS Katusic K. Komori AA Vos and PM Vanhoutte MD Director 《Fundamental & clinical pharmacology》1990,4(5):525-538
Experiments were designed to determine the effect of CRL 41034, a buflomedil analogue, on the adrenergic responsiveness of canine veins. Rings of saphenous vein (without endothelium) were suspended for isometric tension recording in modified Krebs-Ringer bicarbonate solution at 37 degrees C. CRL 41034 produced a concentration-dependent inhibition of the contractions evoked by the alpha adrenergic agonists norepinephrine, phenylephrine and UK 14304 which was insensitive to the blockade of neuronal uptake by cocaine. CRL 41034 was more potent in inhibiting the concentration-dependent contractions evoked by UK 14304 than those by phenylephrine and the antagonism it caused against the response to UK 14304 fulfilled the criteria for competitivity. CRL 41034, at 10(-5) M significantly depressed, and at 10(-4) M abolished the contractions induced by electrical stimulation of the adrenergic nerves and those evoked by the indirect sympathomimetic amine tyramine. Strips of canine saphenous vein were superfused after incubation with [3H] norepinephrine. During sympathetic nerve activation, CRL 41304 increased the stimulation-evoked overflow of [3H] norepinephrine and 3-methoxy-4-dihydroxyphenylglycol; in the presence of rauwolscine the compound only increased the stimulation-evoked overflow of 3,4-dihydroxyphenylglycol. These experiments suggest that the major vascular effects of CRL 41034 in canine veins are blockade of alpha 2-adrenoceptors on vascular smooth muscle, and inhibition of prejunctional alpha 2-adrenoceptors on adrenergic nerve endings. 相似文献